Product
Troxerutin + Low Molecular Weight Heparin
1 clinical trial
1 indication
Indication
COVID-19 Associated CoagulopathyClinical trial
A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 PatientsStatus: Recruiting, Estimated PCD: 2024-09-01